{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:14:46Z","timestamp":1791360886434,"version":"4.3.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CU Gates Grubstake Fund Research to Prevent Blindness"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ocular hypertension is a significant risk factor for vision loss in glaucoma due to the death of retinal ganglion cells (RGCs). This study investigated the effects of the antiapoptotic peptides peptain-1 and peptain-3a on RGC death in vitro in rat primary RGCs and in mouse models of ocular hypertension. Apoptosis was induced in primary rat RGCs by trophic factor deprivation for 48\u2009h in the presence or absence of peptains. The effects of intravitreally injected peptains on RGC death were investigated in mice subjected to retinal ischemic\/reperfusion (I\/R) injury and elevated intraocular pressure (IOP). I\/R injury was induced in mice by elevating the IOP to 120\u2009mm Hg for 1\u2009h, followed by rapid reperfusion. Ocular hypertension was induced in mice by injecting microbeads (MB) or silicone oil (SO) into the anterior chamber of the eye. Retinal flatmounts were immunostained with RGC and activated glial markers. Effects on anterograde axonal transport were determined by intravitreal injection of cholera toxin-B. Peptain-1 and peptain-3a inhibited neurotrophic factor deprivation-mediated RGC apoptosis by 29% and 35%, respectively. I\/R injury caused 52% RGC loss, but peptain-1 and peptain-3a restricted RGC loss to 13% and 16%, respectively. MB and SO injections resulted in 31% and 36% loss in RGCs following 6 weeks and 4 weeks of IOP elevation, respectively. Peptain-1 and peptain-3a inhibited RGC death; the loss was only 4% and 12% in MB-injected eyes and 16% and 15% in SO-injected eyes, respectively. Anterograde transport was defective in eyes with ocular hypertension, but this defect was substantially ameliorated in peptain-injected eyes. Peptains suppressed ocular hypertension-mediated retinal glial activation. In summary, our results showed that peptains block RGC somal and axonal damage and neuroinflammation in animal models of glaucoma. We propose that peptains have the potential to be developed as therapeutics against neurodegeneration in glaucoma.<\/jats:p>","DOI":"10.1038\/s41419-022-05407-2","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T10:09:59Z","timestamp":1668506999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5431-3980","authenticated-orcid":false,"given":"Mi-Hyun","family":"Nam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota L.","family":"Stankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rooban B.","family":"Nahomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina B.","family":"Pantcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-8847","authenticated-orcid":false,"given":"Ram H.","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"5407_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92971-w","volume":"11","author":"N Zhang","year":"2021","unstructured":"Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11:13762.","journal-title":"Sci Rep"},{"key":"5407_CR2","first-page":"e11686","volume":"12","author":"K Allison","year":"2020","unstructured":"Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus 2020;12:e11686.","journal-title":"Cureus"},{"key":"5407_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","volume":"31","author":"M Almasieh","year":"2012","unstructured":"Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res. 2012;31:152\u201381.","journal-title":"Prog Retin Eye Res"},{"key":"5407_CR4","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1001\/archopht.1980.01020041015002","volume":"98","author":"MF Armaly","year":"1980","unstructured":"Armaly MF, Krueger DE, Maunder L, Becker B, Hetherington J Jr., Kolker AE, et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. 1980;98:2163\u201371.","journal-title":"Arch Ophthalmol"},{"key":"5407_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60558-6","volume":"10","author":"RM Chaphalkar","year":"2020","unstructured":"Chaphalkar RM, Stankowska DL, He S, Kodati B, Phillips N, Prah J, et al. Endothelin-1 mediated decrease in mitochondrial gene expression and bioenergetics contribute to neurodegeneration of retinal ganglion cells. Sci Rep. 2020;10:3571.","journal-title":"Sci Rep"},{"key":"5407_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.exer.2010.07.015","volume":"93","author":"S Lee","year":"2011","unstructured":"Lee S, Van Bergen NJ, Kong GY, Chrysostomou V, Waugh HS, O\u2019Neill EC, et al. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies. Exp Eye Res. 2011;93:204\u201312.","journal-title":"Exp Eye Res"},{"key":"5407_CR7","doi-asserted-by":"crossref","unstructured":"Fan Gaskin JC, Shah MH, Chan EC. Oxidative stress and the role of NADPH oxidase in glaucoma. Antioxidants. 2021;10:238.","DOI":"10.3390\/antiox10020238"},{"key":"5407_CR8","doi-asserted-by":"crossref","unstructured":"Canto A, Olivar T, Romero FJ, Miranda M. Nitrosative stress in retinal pathologies: review. Antioxidants. 2019;8:543.","DOI":"10.3390\/antiox8110543"},{"key":"5407_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejphar.2016.03.064","volume":"787","author":"R Russo","year":"2016","unstructured":"Russo R, Varano GP, Adornetto A, Nucci C, Corasaniti MT, Bagetta G, et al. Retinal ganglion cell death in glaucoma: exploring the role of neuroinflammation. Eur J Pharm. 2016;787:134\u201342.","journal-title":"Eur J Pharm"},{"key":"5407_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2147\/OPTH.S3361","volume":"2","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol. 2008;2:879\u201389.","journal-title":"Clin Ophthalmol"},{"key":"5407_CR11","doi-asserted-by":"crossref","unstructured":"Alarcon-Martinez L, Shiga Y, Villafranca-Baughman D, Belforte N, Quintero H, Dotigny F, et al. Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma. Proc Natl Acad Sci USA. 2022;119:e2110329119.","DOI":"10.1073\/pnas.2110329119"},{"key":"5407_CR12","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41433-018-0050-2","volume":"32","author":"C Nucci","year":"2018","unstructured":"Nucci C, Martucci A, Giannini C, Morrone LA, Bagetta G, Mancino R. Neuroprotective agents in the management of glaucoma. Eye. 2018;32:938\u201345.","journal-title":"Eye"},{"key":"5407_CR13","doi-asserted-by":"publisher","first-page":"166325","DOI":"10.1016\/j.bbadis.2021.166325","volume":"1868","author":"RK Somvanshi","year":"2022","unstructured":"Somvanshi RK, Zou S, Kadhim S, Padania S, Hsu E, Kumar U. Cannabinol modulates neuroprotection and intraocular pressure: a potential multi-target therapeutic intervention for glaucoma. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166325.","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"5407_CR14","doi-asserted-by":"publisher","first-page":"108623","DOI":"10.1016\/j.exer.2021.108623","volume":"208","author":"N Nakamura","year":"2021","unstructured":"Nakamura N, Honjo M, Yamagishi R, Kurano M, Yatomi Y, Watanabe S, et al. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death. Exp Eye Res. 2021;208:108623.","journal-title":"Exp Eye Res."},{"key":"5407_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01199-3","volume":"19","author":"X Lou","year":"2021","unstructured":"Lou X, Hu Y, Zhang H, Liu J, Zhao Y. Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury. J Nanobiotechnol. 2021;19:436.","journal-title":"J Nanobiotechnol"},{"key":"5407_CR16","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.exer.2021.108728","volume":"210","author":"D Liu","year":"2021","unstructured":"Liu D, Deng Q, Lei X, Lu W, Zhao Q, Shen Y. Overexpression of BMP4 protects retinal ganglion cells in a mouse model of experimental glaucoma. Exp Eye Res. 2021;210:108728.","journal-title":"Exp Eye Res"},{"key":"5407_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.63.2.5","volume":"63","author":"R Lani-Louzada","year":"2022","unstructured":"Lani-Louzada R, Marra C, Dias MS, de Araujo VG, Abreu CA, Ribas VT, et al. Neuroprotective gene therapy by overexpression of the transcription factor MAX in rat models of glaucomatous neurodegeneration. Invest Ophthalmol Vis Sci. 2022;63:5.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5407_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41434-021-00219-z","volume":"28","author":"AG Ross","year":"2021","unstructured":"Ross AG, McDougald DS, Khan RS, Duong TT, Dine KE, Aravand P, et al. Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1. Gene Ther. 2021;28:256\u201364.","journal-title":"Gene Ther"},{"key":"5407_CR19","doi-asserted-by":"crossref","unstructured":"Wojcik-Gryciuk A, Gajewska-Wozniak O, Kordecka K, Boguszewski PM, Waleszczyk W, Skup M. Neuroprotection of retinal ganglion cells with AAV2-BDNF pretreatment restoring normal TrkB receptor protein levels in glaucoma. Int J Mol Sci. 2020;21:6262.","DOI":"10.3390\/ijms21176262"},{"key":"5407_CR20","first-page":"409","volume":"26","author":"AL Shiozawa","year":"2020","unstructured":"Shiozawa AL, Igarashi T, Kobayashi M, Nakamoto K, Kameya S, Fujishita S, et al. Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of N-methyl-D-aspartate (NMDA). Mol Vis. 2020;26:409\u201322.","journal-title":"Mol Vis"},{"key":"5407_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3389\/fphar.2019.01047","volume":"10","author":"JM Webster","year":"2019","unstructured":"Webster JM, Darling AL, Uversky VN, Blair LJ. Small heat shock proteins, big impact on protein aggregation in neurodegenerative disease. Front Pharm. 2019;10:1047.","journal-title":"Front Pharm"},{"key":"5407_CR22","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1074\/jbc.REV118.002809","volume":"294","author":"M Haslbeck","year":"2019","unstructured":"Haslbeck M, Weinkauf S, Buchner J. Small heat shock proteins: Simplicity meets complexity. J Biol Chem. 2019;294:2121\u201332.","journal-title":"J Biol Chem"},{"key":"5407_CR23","doi-asserted-by":"crossref","unstructured":"Janowska MK, Baughman HER, Woods CN, Klevit RE. Mechanisms of small heat shock proteins. Cold Spring Harb Perspect Biol; 2019.","DOI":"10.1101\/cshperspect.a034025"},{"key":"5407_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jmb.2016.11.013","volume":"429","author":"JN Rauch","year":"2017","unstructured":"Rauch JN, Tse E, Freilich R, Mok SA, Makley LN, Southworth DR, et al. BAG3 is a modular, scaffolding protein that physically links heat shock protein 70 (Hsp70) to the small heat shock proteins. J Mol Biol. 2017;429:128\u201341.","journal-title":"J Mol Biol"},{"key":"5407_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbagen.2015.03.012","volume":"1860","author":"RH Nagaraj","year":"2016","unstructured":"Nagaraj RH, Nahomi RB, Mueller NH, Raghavan CT, Ammar DA, Petrash JM. Therapeutic potential of alpha-crystallin. Biochim Biophys Acta. 2016;1860:252\u20137.","journal-title":"Biochim Biophys Acta."},{"key":"5407_CR26","doi-asserted-by":"publisher","first-page":"38731","DOI":"10.1074\/jbc.M201770200","volume":"277","author":"MC Kamradt","year":"2002","unstructured":"Kamradt MC, Chen F, Sam S, Cryns VL. The small heat shock protein alpha B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J Biol Chem. 2002;277:38731\u20136.","journal-title":"J Biol Chem"},{"key":"5407_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/sj.cdd.4401384","volume":"11","author":"YW Mao","year":"2004","unstructured":"Mao YW, Liu JP, Xiang H, Li DW. Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ. 2004;11:512\u201326.","journal-title":"Cell Death Differ"},{"key":"5407_CR28","doi-asserted-by":"publisher","first-page":"11059","DOI":"10.1074\/jbc.M413382200","volume":"280","author":"MC Kamradt","year":"2005","unstructured":"Kamradt MC, Lu M, Werner ME, Kwan T, Chen F, Strohecker A, et al. The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J Biol Chem. 2005;280:11059\u201366.","journal-title":"J Biol Chem"},{"key":"5407_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-019-0194-2","volume":"5","author":"DL Stankowska","year":"2019","unstructured":"Stankowska DL, Nam MH, Nahomi RB, Chaphalkar RM, Nandi SK, Fudala R, et al. Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma. Cell Death Discov. 2019;5:112.","journal-title":"Cell Death Discov"},{"key":"5407_CR30","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1167\/iovs.08-3138","volume":"50","author":"Y Munemasa","year":"2009","unstructured":"Munemasa Y, Kwong JM, Caprioli J, Piri N. The role of alphaA- and alphaB-crystallins in the survival of retinal ganglion cells after optic nerve axotomy. Invest Ophthalmol Vis Sci. 2009;50:3869\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5407_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.exer.2010.11.008","volume":"92","author":"PE Fort","year":"2011","unstructured":"Fort PE, Lampi KJ. New focus on alpha-crystallins in retinal neurodegenerative diseases. Exp Eye Res. 2011;92:98\u2013103.","journal-title":"Exp Eye Res"},{"key":"5407_CR32","doi-asserted-by":"crossref","unstructured":"Anders F, Liu A, Mann C, Teister J, Lauzi J, Thanos S, et al. The small heat shock protein alpha-crystallin B shows neuroprotective properties in a glaucoma animal model. Int J Mol Sci. 2017;18:2418.","DOI":"10.3390\/ijms18112418"},{"key":"5407_CR33","doi-asserted-by":"publisher","first-page":"7205408","DOI":"10.1155\/2017\/7205408","volume":"2017","author":"H Yan","year":"2017","unstructured":"Yan H, Peng Y, Huang W, Gong L, Li L. The protective effects of alphaB-crystallin on ischemia-reperfusion injury in the rat retina. J Ophthalmol. 2017;2017:7205408.","journal-title":"J Ophthalmol"},{"key":"5407_CR34","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1021\/bi0518141","volume":"45","author":"J Bhattacharyya","year":"2006","unstructured":"Bhattacharyya J, Padmanabha Udupa EG, Wang J, Sharma KK. Mini-alphaB-crystallin: a functional element of alphaB-crystallin with chaperone-like activity. Biochemistry 2006;45:3069\u201376.","journal-title":"Biochemistry"},{"key":"5407_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/bi5014479","volume":"54","author":"PR Banerjee","year":"2015","unstructured":"Banerjee PR, Pande A, Shekhtman A, Pande J. Molecular mechanism of the chaperone function of mini-alpha-crystallin, a 19-residue peptide of human alpha-crystallin. Biochemistry 2015;54:505\u201315.","journal-title":"Biochemistry"},{"key":"5407_CR36","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1167\/iovs.12-11571","volume":"54","author":"PG Sreekumar","year":"2013","unstructured":"Sreekumar PG, Chothe P, Sharma KK, Baid R, Kompella U, Spee C, et al. Antiapoptotic properties of alpha-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells. Invest Ophthalmol Vis Sci. 2013;54:2787\u201398.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5407_CR37","doi-asserted-by":"publisher","first-page":"13022","DOI":"10.1074\/jbc.M112.440214","volume":"288","author":"RB Nahomi","year":"2013","unstructured":"Nahomi RB, Wang B, Raghavan CT, Voss O, Doseff AI, Santhoshkumar P, et al. Chaperone peptides of alpha-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataracts. J Biol Chem. 2013;288:13022\u201335.","journal-title":"J Biol Chem"},{"key":"5407_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1042\/BJ20140837","volume":"465","author":"RB Nahomi","year":"2015","unstructured":"Nahomi RB, DiMauro MA, Wang B, Nagaraj RH. Identification of peptides in human Hsp20 and Hsp27 that possess molecular chaperone and anti-apoptotic activities. Biochem J. 2015;465:115\u201325.","journal-title":"Biochem J"},{"key":"5407_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, et al. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20:294.","journal-title":"BMC Ophthalmol"},{"key":"5407_CR40","doi-asserted-by":"publisher","first-page":"632307","DOI":"10.1155\/2014\/632307","volume":"2014","author":"FR Stefanini","year":"2014","unstructured":"Stefanini FR, Badaro E, Falabella P, Koss M, Farah ME, Maia M. Anti-VEGF for the management of diabetic macular edema. J Immunol Res. 2014;2014:632307.","journal-title":"J Immunol Res"},{"key":"5407_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.3","volume":"1","author":"N Pasupuleti","year":"2010","unstructured":"Pasupuleti N, Matsuyama S, Voss O, Doseff AI, Song K, Danielpour D, et al. The anti-apoptotic function of human alphaA-crystallin is directly related to its chaperone activity. Cell Death Dis. 2010;1:e31.","journal-title":"Cell Death Dis"},{"key":"5407_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91\u2013147.","journal-title":"Prog Retin Eye Res"},{"key":"5407_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.exer.2006.01.025","volume":"83","author":"JH Urcola","year":"2006","unstructured":"Urcola JH, Hernandez M, Vecino E. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp Eye Res. 2006;83:429\u201337.","journal-title":"Exp Eye Res"},{"key":"5407_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1167\/iovs.09-3947","volume":"51","author":"RM Sappington","year":"2010","unstructured":"Sappington RM, Carlson BJ, Crish SD, Calkins DJ. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci. 2010;51:207\u201316.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5407_CR45","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.exer.2006.01.015","volume":"83","author":"QC Ngumah","year":"2006","unstructured":"Ngumah QC, Buchthal SD, Dacheux RF. Longitudinal non-invasive proton NMR spectroscopy measurement of vitreous lactate in a rabbit model of ocular hypertension. Exp Eye Res. 2006;83:390\u2013400.","journal-title":"Exp Eye Res"},{"key":"5407_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0165-0270(01)00443-5","volume":"111","author":"AJ Weber","year":"2001","unstructured":"Weber AJ, Zelenak D. Experimental glaucoma in the primate induced by latex microspheres. J Neurosci Methods. 2001;111:39\u201348.","journal-title":"J Neurosci Methods"},{"key":"5407_CR47","first-page":"e53731","volume":"109","author":"YA Ito","year":"2016","unstructured":"Ito YA, Belforte N, Cueva Vargas JL, Di, Polo A. A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice. J Vis Exp. 2016;109:e53731.","journal-title":"J Vis Exp"},{"key":"5407_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.245465","volume":"14","author":"A Adornetto","year":"2019","unstructured":"Adornetto A, Russo R, Parisi V. Neuroinflammation as a target for glaucoma therapy. Neural Regener Res. 2019;14:391\u20134.","journal-title":"Neural Regener Res"},{"key":"5407_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","volume":"43","author":"N Cuenca","year":"2014","unstructured":"Cuenca N, Fernandez-Sanchez L, Campello L, Maneu V, De la Villa P, Lax P, et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res. 2014;43:17\u201375.","journal-title":"Prog Retin Eye Res"},{"key":"5407_CR50","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","volume":"9","author":"AI Ramirez","year":"2017","unstructured":"Ramirez AI, de Hoz R, Salobrar-Garcia E, Salazar JJ, Rojas B, Ajoy D, et al. The role of microglia in retinal neurodegeneration: Alzheimer\u2019s disease, parkinson, and glaucoma. Front Aging Neurosci. 2017;9:214.","journal-title":"Front Aging Neurosci"},{"key":"5407_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-92","volume":"9","author":"BI Gallego","year":"2012","unstructured":"Gallego BI, Salazar JJ, de Hoz R, Rojas B, Ramirez AI, Salinas-Navarro M, et al. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J Neuroinflammation. 2012;9:92.","journal-title":"J Neuroinflammation"},{"key":"5407_CR52","doi-asserted-by":"crossref","unstructured":"Zhang J, Li L, Huang H, Fang F, Webber HC, Zhuang P, et al. Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse. Elife. 2019;8:e45881.","DOI":"10.7554\/eLife.45881"},{"key":"5407_CR53","first-page":"354","volume":"27","author":"J Fang","year":"2021","unstructured":"Fang J, Hou F, Wu S, Liu Y, Wang L, Zhang J, et al. Piezo2 downregulation via the Cre-lox system affects aqueous humor dynamics in mice. Mol Vis. 2021;27:354\u201364.","journal-title":"Mol Vis"},{"key":"5407_CR54","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.exer.2009.02.004","volume":"88","author":"EC Johnson","year":"2009","unstructured":"Johnson EC, Guo Y, Cepurna WO, Morrison JC. Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models. Exp Eye Res. 2009;88:808\u201315.","journal-title":"Exp Eye Res"},{"key":"5407_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbagen.2015.06.010","volume":"1860","author":"M Raju","year":"2016","unstructured":"Raju M, Santhoshkumar P, Krishna Sharma K. Alpha-crystallin-derived peptides as therapeutic chaperones. Biochim Biophys Acta. 2016;1860:246\u201351.","journal-title":"Biochim Biophys Acta."},{"key":"5407_CR56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fneur.2018.00338","volume":"9","author":"E Yang","year":"2018","unstructured":"Yang E, Al-Mugheiry TS, Normando EM, Cordeiro MF. Real-time imaging of retinal cell apoptosis by confocal scanning laser ophthalmoscopy and its role in glaucoma. Front Neurol. 2018;9:338.","journal-title":"Front Neurol"},{"key":"5407_CR57","first-page":"60","volume":"6","author":"Y Munemasa","year":"2012","unstructured":"Munemasa Y, Kitaoka Y. Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection. Front Cell Neurosci. 2012;6:60.","journal-title":"Front Cell Neurosci"},{"key":"5407_CR58","doi-asserted-by":"crossref","unstructured":"Sreekumar PG, Wang M, Spee C, Sadda SR, Kannan R. Transporter-mediated mitochondrial GSH depletion leading to mitochondrial dysfunction and rescue with alphab crystallin peptide in RPE Cells. Antioxidants. 2020;9:411.","DOI":"10.3390\/antiox9050411"},{"key":"5407_CR59","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.preteyeres.2019.07.002","volume":"73","author":"SB Syc-Mazurek","year":"2019","unstructured":"Syc-Mazurek SB, Libby RT. Axon injury signaling and compartmentalized injury response in glaucoma. Prog Retin Eye Res. 2019;73:100769.","journal-title":"Prog Retin Eye Res"},{"key":"5407_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1379\/1466-1268(2002)007<0167:ACASHS>2.0.CO;2","volume":"7","author":"N Mounier","year":"2002","unstructured":"Mounier N, Arrigo AP. Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones. 2002;7:167\u201376.","journal-title":"Cell Stress Chaperones"},{"key":"5407_CR61","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1016\/j.yexcr.2006.07.025","volume":"312","author":"N Launay","year":"2006","unstructured":"Launay N, Goudeau B, Kato K, Vicart P, Lilienbaum A. Cell signaling pathways to alphaB-crystallin following stresses of the cytoskeleton. Exp Cell Res. 2006;312:3570\u201384.","journal-title":"Exp Cell Res"},{"key":"5407_CR62","doi-asserted-by":"crossref","unstructured":"Muench NA, Patel S, Maes ME, Donahue RJ, Ikeda A, Nickells RW. The influence of mitochondrial dynamics and function on retinal ganglion cell susceptibility in optic nerve disease. Cells. 2021;10:1593.","DOI":"10.3390\/cells10071593"},{"key":"5407_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nbd.2014.11.014","volume":"74","author":"JH Wu","year":"2015","unstructured":"Wu JH, Zhang SH, Nickerson JM, Gao FJ, Sun Z, Chen XY, et al. Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma. Neurobiol Dis. 2015;74:167\u201379.","journal-title":"Neurobiol Dis"},{"key":"5407_CR64","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.cellsig.2013.07.027","volume":"25","author":"L Zeng","year":"2013","unstructured":"Zeng L, Tan J, Lu W, Lu T, Hu Z. The potential role of small heat shock proteins in mitochondria. Cell Signal. 2013;25:2312\u20139.","journal-title":"Cell Signal"},{"key":"5407_CR65","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","volume":"104","author":"NM Tran","year":"2019","unstructured":"Tran NM, Shekhar K, Whitney IE, Jacobi A, Benhar I, Hong G, et al. Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal neuroprotective genes. Neuron 2019;104:1039\u201355.e12.","journal-title":"Neuron"},{"key":"5407_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1167\/iovs.11-8525","volume":"53","author":"LM Ventura","year":"2012","unstructured":"Ventura LM, Feuer WJ, Porciatti V. Progressive loss of retinal ganglion cell function is hindered with IOP-lowering treatment in early glaucoma. Invest Ophthalmol Vis Sci. 2012;53:659\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5407_CR67","doi-asserted-by":"crossref","unstructured":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429\u201340.","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"5407_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.4.2.1","volume":"4","author":"R Susanna Jr","year":"2015","unstructured":"Susanna R Jr, De Moraes CG, Cioffi GA, Ritch R. Why do people (still) go blind from glaucoma? Transl Vis Sci Technol. 2015;4:1.","journal-title":"Transl Vis Sci Technol"},{"key":"5407_CR69","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1167\/iovs.14-15008","volume":"56","author":"DL Stankowska","year":"2015","unstructured":"Stankowska DL, Minton AZ, Rutledge MA, Mueller BH 2nd, Phatak NR, He S, et al. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Invest Ophthalmol Vis Sci. 2015;56:893\u2013907.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5407_CR70","doi-asserted-by":"crossref","unstructured":"Nahomi RB, Nam MH, Rankenberg J, Rakete S, Houck JA, Johnson GC, et al. Kynurenic acid protects against ischemia\/reperfusion-induced retinal ganglion cell death in mice. Int J Mol Sci. 2020;21:1795.","DOI":"10.3390\/ijms21051795"},{"key":"5407_CR71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.09-5115","volume":"52","author":"HH Chen","year":"2011","unstructured":"Chen HH, Wei X, Cho KS, Chen GC, Sappington R, Calkins DJ, et al. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse. Invest Ophth Vis Sci. 2011;52:36\u201344.","journal-title":"Invest Ophth Vis Sci."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05407-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T04:06:49Z","timestamp":1668658009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05407-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":71,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["5407"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05407-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1735340\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"7 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"958"}}